According to a recent LinkedIn post from Veeam Software, SickKids Research Institute is using the company’s technology to protect and recover large, complex research datasets. The post highlights that improving data recovery, combined with new disk technology, has reduced recovery times by up to 70% for the pediatric research center.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
The post suggests that Veeam’s offerings are addressing mission-critical data continuity needs in healthcare research, where system interruptions can delay experiments and extend project timelines. For investors, this use case points to Veeam’s relevance in data-intensive, high-value verticals, potentially supporting pricing power, stickier customer relationships, and future demand for its data protection solutions.
The reference to measurable performance gains at a prominent institution may also serve as social proof in enterprise sales cycles, especially within healthcare and life sciences. If replicated across similar organizations, such deployments could expand Veeam’s footprint in regulated and research-driven sectors, reinforcing its competitive position against other backup and recovery vendors.